Literature DB >> 3259262

Distinctive actions of epidermal growth factor-urogastrone in isolated smooth muscle preparations from guinea pig stomach: differential inhibition by indomethacin.

I Muramatsu1, H Itoh, K Lederis, M D Hollenberg.   

Abstract

Epidermal growth factor-urogastrone (murine EGF-URO) caused concentration-dependent contractile responses in preparations of longitudinal and circular smooth muscle derived from guinea pig stomach. The actions of EGF-URO in these two preparations were distinguished in terms of the ability of indomethacin to block EGF-URO-mediated contraction completely in the longitudinal muscle preparation but not in the circular muscle preparation. The EC50 for EGF-URO was 2 to 5 nM in the longitudinal muscle preparations and 20 to 50 nM in the indomethacin-treated circular muscle preparation. The action of EGF-URO in the longitudinal preparation also was inhibited by ibuprofen, aspirin and by anti-inflammatory steroids possessing an 11-beta-hydroxyl; the corresponding steroids lacking the 11-beta-hydroxyl substituent were inactive. In contrast, little or no effect of the anti-inflammatory steroids on the EGF-URO-mediated response was observed in the indomethacin-treated circular muscle preparation. Partial inhibition (about 30%) of the EGF-URO-mediated contraction of the indomethacin-sensitive longitudinal preparation was caused by mepacrine and p-bromophenyl-acylbromide, whereas esculetine, tranylcypromine, prazosin, yohimbine and cyproheptadine had no effect. The action of EGF-URO in both preparations exhibited marked tachyphyllaxis, which could not be attributed either to the production of inhibitory factors or to the disappearance of EGF-URO from the organ bath. The response of both preparations required the presence of extracellular calcium and was inhibited largely (90%, longitudinal preparation) or in part (69%, indomethacin-treated circular preparation) by verapamil.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259262

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Contractile actions of proteinase-activated receptor-derived polypeptides in guinea-pig gastric and lung parenchymal strips: evidence for distinct receptor systems.

Authors:  M Saifeddine; B Al-Ani; S Sandhu; S J Wijesuriya; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  A redox-based mechanism for the contractile and relaxing effects of NO in the guinea-pig gall bladder.

Authors:  S Alcón; S Morales; P J Camello; J M Hemming; L Jennings; G M Mawe; M J Pozo
Journal:  J Physiol       Date:  2001-05-01       Impact factor: 5.182

3.  Localization of epidermal growth factor/transforming growth factor-alpha receptor in the human gastric mucosa. An immunohistochemical and in situ hybridization study.

Authors:  B Orsini; A Calabrò; S Milani; C Grappone; H Herbst; C Surrenti
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 4.  Protein tyrosine phosphorylation in cardiovascular system.

Authors:  A K Srivastava
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

5.  The tyrosine kinase activity of the epidermal-growth-factor receptor is necessary for phospholipase A2 activation.

Authors:  H J Goldberg; M M Viegas; B L Margolis; J Schlessinger; K L Skorecki
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

6.  Urotensin I-CRF-Urocortins: a mermaid's tail.

Authors:  Quentin J Pittman; Morley D Hollenberg
Journal:  Gen Comp Endocrinol       Date:  2009-05-04       Impact factor: 2.822

Review 7.  Tyrosine kinase-mediated signal transduction pathways and the actions of polypeptide growth factors and G-protein-coupled agonists in smooth muscle.

Authors:  M D Hollenberg
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.